Clinical efficacy of recombinant activated factor VII (rFVIIa) during acute bleeding episode and surgery in a patient with acquired hemophilia A with high inhibitor titer.
Franchini
M
M
Servizio di Immunoematologia e Trasfusione, Centro Emofilia, Ospedale Policlinico, Azienda Ospedaliera di Verona, Verona, Italy.
Capra
F
F
Capelli
C
C
de Maria
E
E
Lippi
G
G
Gandini
G
G
D001323:Autoantibodies / Q000097:blood; D016063:Blood Loss, Surgical / Q000517:prevention & control; D005167:Factor VII / Q000008:administration & dosage*; D005169:Factor VIII / Q000276:immunology; D015942:Factor VIIa; D017809:Fatal Outcome; D005260:Female; D006467:Hemophilia A / Q000150:complications / Q000188:drug therapy* / Q000276:immunology / Q000601:surgery; D006470:Hemorrhage / Q000188:drug therapy*; D006801:Humans; D011994:Recombinant Proteins / Q000008:administration & dosage*
D001323:Autoantibodies; D011994:Recombinant Proteins; D005167:Factor VII; D005169:Factor VIII; C103587:recombinant FVIIa; D015942:Factor VIIa